Position in BIIB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$34,581,915
+$33,272,756 QoQ
Shares Held
160,057
+2141.4% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#78
of 1,036 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $456,999,043 across 8 Drug Manufacturers - General names. BIIB ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,357,537 | $171,511,224 | |
| 2 | ABBV |
AbbVie Inc.
|
510,735 | $128,521,355 | |
| 3 | PFE |
Pfizer Inc
|
2,627,160 | $63,262,012 | |
| 4 | LLY |
ELI LILLY & Co
|
29,495 | $35,377,190 | |
| 5 | BIIB |
Biogen Inc.
This page
|
160,057 | $34,581,915 | |
| 6 | JNJ |
Johnson & Johnson
|
61,648 | $15,656,741 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
132,573 | $7,638,856 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,500 | $449,750 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,581,915 | 160,057 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,309,159 | 7,141 | Shares | Sole | 2026-05-12 | |
| 2023-09-30 | $10,609,114 | 41,279 | Shares | Defined | 2023-11-09 | |
| 2021-12-31 | $9,257,073 | 38,584 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,293,149 | 57,575 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,959,625 | 14,323 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $16,336,814 | 66,719 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,384,246 | 18,980 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||